Zydus Lifesciences Stock Price Analysis and Quick Research Report. Is Zydus Lifesciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Zydus Lifesciences. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Zydus Lifesciences has a PE ratio of 33.7505321413367 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Zydus Lifesciences has ROA of 9.362% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Zydus Lifesciences has a Current ratio of 2.3522.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Zydus Lifesciences has a ROE of 15.8701%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Zydus Lifesciences has a Debt to Equity ratio of 0.3139 which means that the company has low proportion of debt in its capital.

• Sales growth: Zydus Lifesciences has reported revenue growth of -24.029% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Zydus Lifesciences for the current financial year is 23.48223615465%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Zydus Lifesciences is Rs 1 and the yield is 0.085%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Zydus Lifesciences is Rs 35.235. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Zydus Lifesciences in Ticker for free. Also, one can get the intrinsic value of Zydus Lifesciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Zydus Lifesciences FAQs

Q1. What is Zydus Lifesciences share price today?
Ans: The current share price of Zydus Lifesciences is Rs 1189.2.

Q2. What is the market capitalisation of Zydus Lifesciences?
Ans: Zydus Lifesciences has a market capitalisation of Rs 118623.15570144 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Zydus Lifesciences?
Ans: The PE ratio of Zydus Lifesciences is 33.7505321413367 and the P/B ratio of Zydus Lifesciences is 5.17748967506158, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Zydus Lifesciences share?
Ans: The 52-week high share price of Zydus Lifesciences is Rs 1205, and the 52-week low share price of Zydus Lifesciences is Rs 835.5.

Q5. Does Zydus Lifesciences pay dividends?
Ans: Currently, Zydus Lifesciences pays dividends. Dividend yield of Zydus Lifesciences is around 0.085%.

Q6. What are the face value and book value of Zydus Lifesciences shares?
Ans: The face value of Zydus Lifesciences shares is Rs 1, while the book value per share of Zydus Lifesciences is around Rs 229.6866. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Zydus Lifesciences?
Ans: Zydus Lifesciences has a total debt of Rs 7431.1 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Zydus Lifesciences?
Ans: The ROE of Zydus Lifesciences is 15.8701% and ROCE of Zydus Lifesciences is 16.0471%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Zydus Lifesciences a good buy for the long term?
Ans: The Zydus Lifesciences long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Zydus Lifesciences undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Zydus Lifesciences appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Zydus Lifesciences’s financials?
Ans: You can review Zydus Lifesciences’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.